发明授权
- 专利标题: Bone morphogenetic protein antagonist based on the mature protein
- 专利标题(中): 基于成熟蛋白的骨形态发生蛋白拮抗剂
-
申请号: US09806368申请日: 1999-10-04
-
公开(公告)号: US07132397B1公开(公告)日: 2006-11-07
- 发明人: Mieko Katsuura , Michio Kimura
- 申请人: Mieko Katsuura , Michio Kimura
- 申请人地址: DE Heidelberg
- 专利权人: Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH
- 当前专利权人: Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH
- 当前专利权人地址: DE Heidelberg
- 代理机构: Rothwell, Figg, Ernst & Manbeck, P.C.
- 优先权: JP10-288103 19981009
- 国际申请: PCT/IB99/01621 WO 19991004
- 国际公布: WO00/21998 WO 20000420
- 主分类号: A61K38/18
- IPC分类号: A61K38/18 ; C07K14/51
摘要:
The purpose is to provide a mature protein having an antagonistic activity against bone morphogenetic proteins. The mature protein having an antagonistic activity against bone morphogenetic proteins is obtained by converting at least one residue among methionine residues or tryptophane residues existing in the amino acid sequence of mature human MP52 (SEQ ID No 1) to a hydrophilic residue by chemical modification, or replacing said residues with a hydrophilic amino acid residue or a polar amino acid residue. The chemical modification for said methionine residue is performed by an oxidization reaction or an alkylation reaction. The chemical modification for said tryptophane residue is performed by an allylsulphenylation reaction. Or a mature protein having an antagonistic activity against bone morphogenetic proteins is obtained by converting at least one residue of tryptophane residues existing in the amino acid sequences of mature human BMP-2 (SEQ ID No 2), mature human BMP-4 (SEQ ID No 3), and mature human BMP-7 (SEQ ID No 4) to a hydrophilic residue by chemical modification, or replacing said residues with a hydrophilic amino acid residue or a polar amino acid residue.
信息查询
IPC分类: